Search Page

1

Cite

Share

A size and space structured model describing interactions of tumor cells with immune cells reveals cancer persistent equilibrium states in tumorigenesis.

Atsou K, Anjuère F, Braud VM, Goudon T. Atsou K, et al. Among authors: anjuere f. J Theor Biol. 2020 Apr 7;490:110163. doi: 10.1016/j.jtbi.2020.110163. Epub 2020 Jan 23. J Theor Biol. 2020. PMID: 31981572

Cite

Share

2

Cite

Share

Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development.

Khou S, Popa A, Luci C, Bihl F, Meghraoui-Kheddar A, Bourdely P, Salavagione E, Cosson E, Rubod A, Cazareth J, Barbry P, Mari B, Rezzonico R, Anjuère F, Braud VM. Khou S, et al. Among authors: anjuere f. Cancers (Basel). 2020 Jul 10;12(7):1860. doi: 10.3390/cancers12071860. Cancers (Basel). 2020. PMID: 32664318 Free PMC article.

Cite

Share

3

Cite

Share

Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.

Luci C, Bihl F, Bourdely P, Khou S, Popa A, Meghraoui-Kheddar A, Vermeulen O, Elaldi R, Poissonnet G, Sudaka A, Bozec A, Bekri S, Cazareth J, Ponzio G, Barbry P, Rezzonico R, Mari B, Braud VM, Anjuère F. Luci C, et al. Among authors: anjuere f. J Invest Dermatol. 2021 Oct;141(10):2369-2379. doi: 10.1016/j.jid.2021.03.018. Epub 2021 Apr 5. J Invest Dermatol. 2021. PMID: 33831432

Cite

Share

4

Cite

Share

High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture.

Elaldi R, Hemon P, Petti L, Cosson E, Desrues B, Sudaka A, Poissonnet G, Van Obberghen-Schilling E, Pers JO, Braud VM, Anjuère F, Meghraoui-Kheddar A. Elaldi R, et al. Among authors: anjuere f. Front Immunol. 2021 Apr 16;12:666233. doi: 10.3389/fimmu.2021.666233. eCollection 2021. Front Immunol. 2021. PMID: 33936105 Free PMC article.

Cite

Share

5

Cite

Share

Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma.

Spenlé C, Loustau T, Murdamoothoo D, Erne W, Beghelli-de la Forest Divonne S, Veber R, Petti L, Bourdely P, Mörgelin M, Brauchle EM, Cremel G, Randrianarisoa V, Camara A, Rekima S, Schaub S, Nouhen K, Imhof T, Hansen U, Paul N, Carapito R, Pythoud N, Hirschler A, Carapito C, Dumortier H, Mueller CG, Koch M, Schenke-Layland K, Kon S, Sudaka A, Anjuère F, Van Obberghen-Schilling E, Orend G. Spenlé C, et al. Among authors: anjuere f. Cancer Immunol Res. 2020 Sep;8(9):1122-1138. doi: 10.1158/2326-6066.CIR-20-0074. Epub 2020 Jul 14. Cancer Immunol Res. 2020. PMID: 32665262 Free article.

Cite

Share

6

Cite

Share

Sublingual vaccination and delivery systems.

Paris AL, Colomb E, Verrier B, Anjuère F, Monge C. Paris AL, et al. Among authors: anjuere f. J Control Release. 2021 Apr 10;332:553-562. doi: 10.1016/j.jconrel.2021.03.017. Epub 2021 Mar 15. J Control Release. 2021. PMID: 33737202 Free article. Review.

Cite

Share

7

Cite

Share

LLT1-CD161 Interaction in Cancer: Promises and Challenges.

Braud VM, Meghraoui-Kheddar A, Elaldi R, Petti L, Germain C, Anjuère F. Braud VM, et al. Among authors: anjuere f. Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022. Front Immunol. 2022. PMID: 35185935 Free PMC article. Review.

Cite

Share

8

Cite

Share

A size and space structured model of tumor growth describes a key role for protumor immune cells in breaking equilibrium states in tumorigenesis.

Atsou K, Anjuère F, Braud VM, Goudon T. Atsou K, et al. Among authors: anjuere f. PLoS One. 2021 Nov 22;16(11):e0259291. doi: 10.1371/journal.pone.0259291. eCollection 2021. PLoS One. 2021. PMID: 34808661 Free PMC article.

Cite

Share

9

Cite

Share

Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes.

Spenlé C, Loustau T, Burckel H, Riegel G, Abou Faycal C, Li C, Yilmaz A, Petti L, Steinbach F, Ahowesso C, Jost C, Paul N, Carapito R, Noël G, Anjuère F, Salomé N, Orend G. Spenlé C, et al. Among authors: anjuere f. Front Immunol. 2021 Jul 5;12:636108. doi: 10.3389/fimmu.2021.636108. eCollection 2021. Front Immunol. 2021. PMID: 34290694 Free PMC article.

Cite

Share

10

Cite

Share

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, Damotte D, Alifano M, Validire P, Anjuère F, Cremer I, Girard N, Gossot D, Seguin-Givelet A, Dieu-Nosjean MC, Germain C. Braud VM, et al. Among authors: anjuere f. Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018. Oncoimmunology. 2018. PMID: 29721382 Free PMC article.

Cite

Share